Robert W Duggan is Director of Pulse Biosciences, Inc.. Currently has a direct ownership of 42.2 Million shares of PLSE, which is worth approximately $725 Million. The most recent transaction as insider was on Jul 03, 2024, when has been sold 5,187,824 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42.2M
14.03% 3M change
16.39% 12M change
Total Value Held $725 Million

ROBERT W DUGGAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 03 2024
BUY
Exercise of in-the-money or at-the-money derivatives securities
-
5,187,824 Added 10.95%
42,172,003 Common Stock
Dec 12 2023
BUY
Open market or private purchase
$164,690 $9.15 p/Share
17,999 Added 0.05%
36,984,179 Common Stock
Dec 11 2023
BUY
Open market or private purchase
$843,504 $9.36 p/Share
90,118 Added 0.24%
36,966,180 Common Stock
Dec 08 2023
BUY
Open market or private purchase
$1,112,898 $9.54 p/Share
116,656 Added 0.32%
36,876,062 Common Stock
Dec 07 2023
BUY
Open market or private purchase
$687,889 $9.19 p/Share
74,852 Added 0.2%
36,759,406 Common Stock
Dec 06 2023
BUY
Exercise of conversion of derivative security
$59,101 $5.95 p/Share
9,933 Added 0.03%
36,601,741 Common Stock
Dec 06 2023
BUY
Open market or private purchase
$750,285 $9.06 p/Share
82,813 Added 0.23%
36,684,554 Common Stock
Dec 04 2023
BUY
Exercise of conversion of derivative security
$430,099 $10.66 p/Share
40,347 Added 0.11%
36,591,808 Common Stock
Nov 29 2023
BUY
Open market or private purchase
$1,497,184 $9.44 p/Share
158,600 Added 0.43%
36,551,461 Common Stock
Nov 29 2023
BUY
Exercise of conversion of derivative security
$9,918 $5.95 p/Share
1,667 Added 0.0%
36,392,861 Common Stock
Nov 28 2023
BUY
Open market or private purchase
$1,117,085 $8.98 p/Share
124,397 Added 0.34%
36,391,194 Common Stock
Nov 17 2023
BUY
Open market or private purchase
$123,470 $6.1 p/Share
20,241 Added 0.06%
36,266,797 Common Stock
Nov 07 2023
BUY
Exercise of conversion of derivative security
$78,926 $5.95 p/Share
13,265 Added 0.04%
36,246,556 Common Stock
Aug 25 2023
BUY
Exercise of conversion of derivative security
$9,918 $5.95 p/Share
1,667 Added 0.0%
36,233,291 Common Stock
Jul 25 2023
BUY
Exercise of conversion of derivative security
$9,918 $5.95 p/Share
1,667 Added 0.0%
36,231,624 Common Stock
Jul 07 2023
BUY
Exercise of conversion of derivative security
$271,888 $4.05 p/Share
67,133 Added 0.18%
36,229,957 Common Stock
Jul 05 2023
BUY
Exercise of conversion of derivative security
$139,100 $2.14 p/Share
65,000 Added 0.18%
36,162,824 Common Stock
Jun 14 2023
BUY
Exercise of in-the-money or at-the-money derivatives securities
$11,650,484 $2.05 p/Share
5,683,163 Added 13.6%
36,097,824 Common Stock
May 09 2023
BUY
Open market or private purchase
$65,249,319 $6.51 p/Share
10,022,937 Added 24.79%
30,414,661 Common Stock
Jun 09 2022
BUY
Exercise of in-the-money or at-the-money derivatives securities
-
5,683,163 Added 21.8%
20,391,724 Common Stock
Jun 30 2021
BUY
Open market or private purchase
$49,999,991 $16.4 p/Share
3,048,780 Added 17.17%
14,708,561 Common Stock
Dec 29 2020
BUY
Exercise of in-the-money or at-the-money derivatives securities
$2,636,216 $7.01 p/Share
376,065 Added 3.12%
11,659,781 Common Stock

Also insider at

SMMT
Summit Therapeutics Inc. Healthcare
RWD

Robert W Duggan

Director
Clearwater, FL

Track Institutional and Insider Activities on PLSE

Follow Pulse Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PLSE shares.

Notify only if

Insider Trading

Get notified when an Pulse Biosciences, Inc. insider buys or sells PLSE shares.

Notify only if

News

Receive news related to Pulse Biosciences, Inc.

Track Activities on PLSE